Vinod Khosla

Generative AI is poised to fundamentally restructure the healthcare industry by automating administrative tasks and democratizing access to expert-level medical knowledge. By shifting from legacy fee-for-service models to capitated risk arrangements, health systems can significantly reduce administrative overhead, allowing physicians to double their panel sizes while increasing patient engagement. AI-driven tools in mental health and physical therapy already demonstrate superior diagnostic accuracy and patient outcomes compared to traditional human-only approaches. However, the transition faces significant friction from regulatory capture and entrenched institutional resistance. While the United States navigates these bureaucratic hurdles, geopolitical rivals may accelerate the global adoption of clinical AI. Ultimately, the integration of medical superintelligence promises a deflationary economic shift, potentially moving the industry toward a post-scarcity model where high-quality care becomes widely accessible and affordable.